Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation

Arthritis Research and Therapy

Volumn 9, Issue 4, 2007, Pages

  Tiku, Moti L ^a   Narla, Haritha ^a   Jain, Mohit ^a   Yalamanchili, Praveen ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; CALCIUM IONOPHORE; COLLAGEN; COPPER; GLUCOSAMINE; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ALPHA TOCOPHEROL; ANTIOXIDANT; CARTILAGE MATRIX PROTEIN; GLYCOPROTEIN; LIPOPROTEIN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL ACTIVATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; DRUG MECHANISM; FRAGMENTATION REACTION; IMMUNOBLOTTING; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; OSTEOARTHRITIS; PROTEIN PURIFICATION; ANIMAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; METABOLISM; OXIDATION REDUCTION REACTION; RABBIT;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; CHONDROCYTES; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLUCOSAMINE; GLYCOPROTEINS; LIPID PEROXIDATION; LIPOPROTEINS; MALE; OXIDATION-REDUCTION; RABBITS; VITAMIN E;

EID: 34548305374     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2274     Document Type: Article

References (54)

1. Hamerman D The biology of osteoarthritis N Engl J Med 1989 320 1322-1330 2654632
2. Centers for Disease Control and Prevention (CDC) Update: Direct and indirect costs of arthritis and other rheumatic conditions - United States, 1997 MMWR Morb Mortal Wkly Rep 2004 53 388-389 15138399
3. Reginster JY Deroisy R Rovati LC Lee RL Lejeune E Bruyere O Giacovelli G Henrotin Y Dacre JE Gossett C Long-term effect of glucosamine sulfate on osteoarthritis progression: A randomised, placebo-controlled clinical trial Lancet 2001 357 251-256 10.1016/S0140-6736(00)03610-2 11214126
4. Pavelká K Gatterová J Olejarová M Machacek S Giacovelli G Rovati LC Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study Arch Intern Med 2002 162 2113-2123 10.1001/ archinte.162.18.2113 12374520
5. Bruyere O Pavelka K Rovati LC Deroisy R Olejarova M Gatterova J Giacovelli G Reginster JY Gluocosamine sulfate reduces osteoarthitis progression in postmenopausal women with knee osteoarthritis: Evidence from two 3-year studies Menopause 2004 11 138-143 10.1097/ 01.GME.0000087983.28957.5D 15021442
6. Altman RD Abramson S Bruyere O Clegg D Herrero-Beaumont G Maheu E Moskowitz R Pavelka K Reginster JY Commentary: Osteoarthritis of the knee and glucosamine Osteoarthritis Cartilage 2006 14 963-966 10.1016/ j.joca.2006.06.010 16857394
7. Clegg DO Reda DJ Harris CL Klein MA O'Dell JR Hooper MM Bradley JD Bingham CO 3rd Weisman MH Jackson CG Glucosamine, chondroitin sulfate, and two in combination for painful knee osteoarthritis N Engl J Med 2006 354 795-808 10.1056/NEJMoa052771 16495392
8. Herrero-Beaumont G Ivorra JA Del Carmen Trabado M Blanco FJ Benito P Martín-Mola E Paulino J Marenco JL Porto A Laffon A Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator Arthritis Rheum 2007 56 555-567 10.1002/art.22371 17265490
9. Shikhman AR Kuhn K Alaaeddine N Lotz M N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes J Immunol 2001 166 5155-5160 11290798
10. Meininger CJ Kelly KA Li H Haynes TE Wu G Glucosamine inhibit inducible nitric oxide synthesis Biochem Biophys Res Commun 2000 279 234-239 10.1006/bbrc.2000.3912 11112445
11. Piperno M Reboul P Hellio Le Graverand MP Peschard MJ Annefeld M Richard M Vignon E Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro Osteoarthritis Cartilage 2000 8 207-212 10.1053/joca.1999.0291 10806048
12. Ilic MZ Martinac B Handley CJ Effect of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage Osteoarthritis Cartilage 2003 11 613-622 10.1016/ S1063-4584(03)00092-X 12880584
13. Fenton JI Chlebek-Brown KA Peters TL Caron JP Orth MW Glucosamine HCL reduces equine articular cartilage degradation in explant culture Osteoarthritis Cartilage 2000 8 258-265 10.1053/joca.1999.0299 10903879
14. Bassleer C Rovati L Franchimont P Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro Osteoarthritis Cartilage 1998 6 427-434 10.1053/joca.1998.0146 10343776
15. Dodge GR Jimenez SA Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes Osteoarthritis Cartilage 2003 11 424-432 10.1016/S1063-4584(03)00052-9 12801482
16. Sandy JD Gamett D Thompson V Verscharen C Chondrocyte-mediated catabolism of aggrecan: Aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine Biochem J 1988 335 59-66
17. Sandy JD Thompson V Verscharen C Gamett D Chondrocyte-mediated catabolism of aggrecan: Evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid Arch Biochem Biophys 1999 367 258-264 10.1006/abbi.1999.1234 10395742
18. Gouze JN Bianchi A Bécuwe P Dauça M Netter P Magdalou J Terlain B Bordji K Glucosamine modulates IL-1 induced activation of rat chondrocytes at receptor level, and by inhibiting the NF-kappa B pathway FEBS Lett 2002 510 166-170 10.1016/S0014-5793(01)03255-0 11801247
19. Largo R Alvarez-Soria MA Díez-Ortego I Calvo E Sánchez-Pernaute O Egido J Herrero-Beaumont G Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes Osteoarthritis Cartilage 2003 11 290-298 10.1016/ S1063-4584(03)00028-1 12681956
20. Lippiello L Woodward J Karpman R Hammad TA In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate Clin Orthop Relat Res 2000 381 229-240 10.1097/00003086-200012000-00027 11127660
21. Shikhman AR Amiel D D'Lima D Hwang SB Hu C Xu A Hashimoto S Kobayashi K Sasho T Lotz MK Chondroprotective activity if N-acetylglucosamine in rabbits with experimental osteoarthritis Ann Rheum Dis 2005 64 89-94 10.1136/ard.2003.019406 15608304
22. Tamai Y Miyatake K Okamoto Y Takamori Y Sakamoto H Minami S Enhanced healing of cartilaginous injuries by glucosamine hydrochloride Carbohydrate Polymers 2002 48 369-378 10.1016/S0144-8617(01)00281-8
23. Tiraloche G Girard C Chouinard L Sampalis J Moquin L Ionescu M Reiner A Poole AR Laverty S Effect of oral glucosamine on cartilage degradation in rabbit model of osteoarthritis Arthritis Rheum 2005 52 1118-1128 10.1002/art.20951 15818693
24. Ma L Rudert WA Harnaha J Wright M Machen J Lakomy R Qian S Lu L Robbins PD Trucco M Immunosuppressive effects of glucosamine J Biol Chem 2002 277 39343-39349 10.1074/jbc.M204924200 12176986
25. Quastel JH Cantero A Inhibition of tumour growth by D-glucosamine Nature 1953 171 252-254 10.1038/171252a0 13036842
26. Tiku ML Shah R Allison GT Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis J Biol Chem 2000 275 20069-20076 10.1074/jbc.M907604199 10867027
27. Rifici VA Khachadurian AK Dietary supplementation with vitamin C and E inhibit in vitro oxidation of lipoproteins J Am Coll Nutr 1993 12 631-637 8294717
28. Lavy A Brook GJ Dankner G Ben Amotz A Aviram M Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients Metabolism 1991 40 794-799 10.1016/0026-0495(91)90005-H 1861629
29. Laemmli UK Cleavage of structural proteins during the assembly of head of bacteriophage T4 Nature 1970 227 680-685 10.1038/227680a0 5432063
30. Palinski W Hörkkö S Miller E Steinbrecher UP Powell HC Curtiss LK Witztum JL Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma J Clin Invest 1996 98 800-814 507491 8698873
31. Shacter EY Williams JA Stadtman ER Determination of carbonyl groups in oxidized proteins Free Radicals: A Practical Approach Oxford University Press, New York: IRL Press Punchard NA, Kelly FJ 1996 159-170
32. Gutteridge JM Lipid peroxidation and antioxidants as biomarkers of tissue damage Clin Chem 1995 41 1819-1828 7497639
33. Berlett BS Stadtman ER Protein oxidation in aging, disease, and oxidative stress J Biol Chem 1997 272 20313-20316 10.1074/ jbc.272.33.20313 9252331
34. Tamarit J Cabiscol E Ros J Identification of major oxidatively damaged proteins in Escherichia coli cells exposed to oxidative stress J Biol Chem 1998 273 3027-3032 10.1074/jbc.273.5.3027 9446617
35. Tiku ML Allison GT Naik K Karry SK Malondialdehyde oxidation of cartilage collagen by chondrocytes Osteoarthritis Cartilage 2003 11 159-166 10.1016/S1063-4584(02)00348-5 12623287
36. Shah R Raska K Jr Tiku ML The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: A pathogenic role in osteoarthritis Arthritis Rheum 2005 52 2799-2807 10.1002/art.21239 16145669
37. Morquette B Shi Q Lavigne P Ranger P Fernandes JC Benderdour M Production of lipid peroxidation products in osteoarthritic tissues: New evidence linking 4-hydroxynonenal to cartilage degradation Arthritis Rheum 2006 54 271-281 10.1002/art.21559 16385544
38. Onorato JM Jenkins AJ Thorpe SR Baynes JW Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine J Biol Chem 2000 275 21177-21184 10.1074/jbc.M003263200 10801874
39. Metz TO Alderson NL Chachich ME Thorpe SR Baynes JW Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: Evidence on the role of lipids in chemical modification of protein and development of diabetic complications J Biol Chem 2003 278 42012-42019 10.1074/ jbc.M304292200 12923193
40. Degenhardt TP Alderson NL Arrington DD Beattie RJ Basgen JM Steffes MW Thorpe SR Baynes JW Pyridoxamine inhibits early renal disease and dyslipidemia in streptozotocin-diabetic rat Kidney Int 2002 61 939-950 10.1046/j.1523-1755.2002.00207.x 11849448
41. Requena JR Vidal P Cabezas-Cerrato J Aminoguanidine inhibits the modification of proteins by lipid peroxidation derived aldehyde: A possible anti-atherogenic agent Diabetes Res 1992 20 43-49 1345001
42. Picard S Parthasarathy S Fruebis J Witztum JL Aminoguanidine inhibits oxidative modification of low-density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors Proc Natl Acad Sci USA 1992 89 6876-6880 49607 1495978 10.1073/pnas.89.15.6876
43. Voziyan PA Metz TO Baynes JW Hudson BG A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediated of carbohydrates and lipid degradation J Biol Chem 2002 277 3397-3403 10.1074/jbc.M109935200 11729198
44. Uchiyama A Ohishi T Takahashi M Kushida K Inoue T Fujie M Horiuchi K Fluorophores from aging human cartilage J Biochem (Tokyo) 1991 110 714-718 1664425
45. Hormel SE Eyre DR Collagen in the ageing human intervertebral disc: An increase in covalently bound fluorophores and chromophores Biochim Biophys Acta 1991 1078 243-250 1905958
46. Pokharna HK Monnier V Boja B Moskowitz RW Lysyl oxidase and Maillard reaction-mediated crosslinks in aging and osteoarthritic rabbit cartilage J Orthop Res 1995 13 13-21 10.1002/jor.1100130105 7853094
47. Baynes JW Thorpe SR Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 1999 48 1-9 10.2337/ diabetes.48.1.1 9892215
48. Nakamura S Makita Z Ishikawa S Yasumura K Fujii W Yanagisawa K Kawata T Koike T Progression of nephropathy in spontaneous diabetic rats is prevented by OPB- a novel inhibitor of advanced glycation Diabetes 1995 46 895-899 10.2337/diabetes.46.5.895
49. Shoda H Miyata S Liu BF Yamada H Ohara T Suzuki K Oimomi M Kasuga M Inhibitory effects of tenilsetam on the Maillard reaction Endocrinology 1997 138 1886-1892 10.1210/en.138.5.1886 9112383
50. Brownlee M Vlassara H Kooney A Ulrich P Cerami A Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 1986 232 1629-1632 10.1126/science.3487117 3487117
51. Lo TW Selwood T Thornalley PJ The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins Biochem Pharmacol 1994 48 1865-1870 10.1016/0006-2952(94)90584-3 7986197
52. Lubec B Aufricht C Amann G Kitzmüller E Höger H Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in diabetic KK mouse Nephron 1997 75 213-218 9041544
53. Ruggiero-Lopez D Lecomte M Moinet G Patereau G Lagarde M Wiernsperger N Reaction of metformin with dicaronyl compounds. Possible implication in the inhibition of advanced glycation end product formation Biochem Pharmacol 1999 58 1765-1773 10.1016/S0006-2952(99)00263-4 10571251
54. Persiani S Roda E Rovati LC Locatelli M Giacovelli G Roda A Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man Osteoarthritis Cartilage 2005 13 1041 1049 10.1016/j.joca.2005.07.009 16168682